Filing Flows › Companies › Fresenius Medical Care AG › Timeline
Fresenius Medical Care AG stock timeline
A year of the price with every insider trade, planned sale, earnings report and material 8-K marked
252 sessions+0.1% to $23.40
Fresenius Medical Care AG (FMS) stock rose 0% over the last 252 sessions, to $23.40. On the way it reported 4 quarters, its insiders filed no open-market trades (10b5-1 plan sales aside), and the company filed 0 material 8-Ks. Each is marked on the price and listed with what the stock did next.
Each mark, and what followed
| Date | Kind | What | Next session | 5 sessions | 21 sessions |
|---|---|---|---|---|---|
| Nov 3, 2026 | Earnings | Earnings: beat the EPS estimate by 4.9% | −4.0% (−4.3% vs SPY) | — | — |
| Aug 3, 2026 | Earnings | Earnings: beat the EPS estimate by 13.1% | −1.6% (−3.0% vs SPY) | −5.6% (−9.0% vs SPY) | −12.1% (−14.7% vs SPY) |
| May 4, 2026 | Earnings | Earnings: missed the EPS estimate by -8.6% | +0.7% (+1.1% vs SPY) | −2.1% (−4.4% vs SPY) | −5.1% (−10.3% vs SPY) |
| Feb 24, 2026 | Earnings | Earnings: beat the EPS estimate by 30.0% | −8.2% (−8.9% vs SPY) | −4.7% (−5.2% vs SPY) | −11.0% (−6.9% vs SPY) |
Report card: every quarter against the estimate → Fresenius Medical Care AG: every quarter → Live insider trades →
Prices are daily closes; filings and trades are as filed with the SEC (Form 4 within two business days of the trade, 8-K within four of the event). Moves after a mark are the stock's close-to-close change and the same for SPY; they describe the record, not what the next one will do. Not investment advice.